RCOphth NOD AMD Audit: First-Year Treatment Outcomes for Neovascular AMD (2020-2021)

The 2020-2021 NHS year (01/04/2020 to 31/03/2021) of the National Age-related Macular Degeneration Audit, covering eyes starting treatment for neovascular AMD. Data was collected from 63 participating clinical centres across the UK as part of routine care, with results reported for centres meeting minimum data thresholds. The audit is produced by the Royal College of Ophthalmologists.

Use Cases

• Benchmarking clinical performance across NHS Trusts and Health Boards based on reported treatment results.
• Analyzing one-year treatment outcomes for neovascular AMD based on the audit's follow-up data.
• Studying geographic variation in AMD care delivery based on data from English, Scottish, Northern Irish, Welsh, and independent sector centres.

Strengths

• Data originates from 63 participating clinical centres, providing a multi-centre perspective.
• Results are reported with specific quality thresholds, such as only including centres with at least 25 eyes for relevant analyses.

Limitations

• Row count and specific column definitions are unknown, which limits suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Royal College of Ophthalmologists

Collection Method

Collected as part of routine clinical care on electronic medical record systems in participating centres.

Time Range

2020-04-01 to 2021-03-31

Freshness

Last updated 2026-06-23 12:44:08.768331; freshness should be verified.

Geography

United Kingdom (England, Scotland, Wales, Northern Ireland), Guernsey